Status:

COMPLETED

Oral Health Promotion Strategy for Persons With Intellectual/Developmental Disabilities

Lead Sponsor:

University of Louisville

Collaborating Sponsors:

National Institute of Dental and Craniofacial Research (NIDCR)

Conditions:

Oral Health

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

A Phase II cluster randomized controlled trial of the (OHPROM) strategy/intervention will be conducted in partnership with several organizations that provide residential services for persons with inte...

Detailed Description

The proposed intervention is comprised of four components : (a) planned action including a behavioral contract Activity 1) with caregivers and action planning for oral health (Activity 2), (b) caregiv...

Eligibility Criteria

Inclusion

  • Persons with IDD: To be eligible to participate in this study, an individual must meet all of the following criteria:
  • Be a resident in a group or family home associated with one of the six partner organizations participating in this study
  • Provide signed and dated informed consent form, to be signed by self or a legally authorized representative (LAR), if one has been appointed
  • Be willing and able to comply with all study procedures and expect to be available for the duration of the study
  • Be aged 18 to 75
  • Have at least six teeth
  • Have diagnosis of mild, moderate, severe, or profound intellectual and/or developmental disability
  • Caregiver staff: To be eligible to participate in this study, caregiver staff must meet all of the following criteria:
  • Work as a direct care staff member in a group/family home
  • Provide signed and dated informed consent form
  • Be willing to comply with all study procedures and be available for the duration of the study
  • Be aged 18 to 75

Exclusion

  • Persons with IDD: Will be excluded (screen failure) if they are unable to cooperate or refuse the oral examination.
  • Caregivers: There are no exclusions.

Key Trial Info

Start Date :

June 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 30 2021

Estimated Enrollment :

412 Patients enrolled

Trial Details

Trial ID

NCT03834064

Start Date

June 1 2018

End Date

November 30 2021

Last Update

October 17 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Louisville

Louisville, Kentucky, United States, 40202